直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Article

Clarifying Provisions Avoid Ambiguity in Patent License Agreement

September 26, 2018

LES Insights

By John C. Paul; D. Brian Kacedon; Sonja W. Sahlsten

Abstract

To interpret an ambiguous term in a license agreement that was subject to several reasonable interpretations, a Delaware court relied on a clarifying provision and read the agreement as a whole.


Background

Lantiq paid Aware to develop DSL technology for Lantiq DSL chips. In return, Lantiq obtained a license to any patents obtained by Aware covering DSL chips. As Aware invented new technology, it entered into new agreements with Lantiq. Lantiq later purchased Aware’s DSL business, acquiring several of Aware’s DSL patents and renewing its license to all other Aware DSL patents.

TQ Delta purchased the patents from Aware, subject to the license with Lantiq. Two years later, TQ Delta sued Adtran for patent infringement. Adtran responded by arguing that its products contained Lantiq chips, and that it therefore had a license to the patents-in-suit. The court agreed that Adtran was licensed.

The TQ Delta Decision

Aware granted Lantiq a license to the patents related to DSL technology that it had not already purchased. A Carve-Out provision stated that “[t]he license does not include a license to patents solely used for or applicable for products compliant with an unlisted xDSL standard.” A Clarity provision stated that “For clarity: the license[ ] includes a license to those patents of Aware for products compliant with other standards provided that those patents are applicable to the aforementioned standards.”

TQ Delta and Adtran disputed whether the patents-in-suit were licensed or carved out of the license. Adtran stated that the asserted patents were not carved out and so were licensed, arguing that patents “solely used for or applicable for products compliant with unlisted xDSL standards” were not licensed, but patents used for or applicable for products compliant with unlisted and listed xDSL standard were licensed. TQ Delta disagreed, stating that the patents-in-suit were carved out and not licensed because, according to TQ Delta a patent is not licensed if the product for which that patent is “used” or “applicable” complies with an unlisted xDSL standard, even if it also complies with a listed xDSL standard.

The court concluded that the language of the Carve-Out provision was ambiguous and that both parties’ constructions were reasonable. But by reading the Carve-Out provision in the context of the Clarity provision, the license as a whole was unambiguous.

The Clarity provision had two rules. First, a patent is licensed if it is applicable to listed xDSL standards. Second, patent is licensed even for products also compliant with unlisted xDSL standards. In other words, the court interpreted the Clarity provision to state that if a patent covers both listed and unlisted standards, it is licensed. Taken as a whole, the Carve-Out and the Clarity provisions only supported Adtran’s interpretation.

Strategy and Conclusion

This case demonstrates the value of clarifying provisions, which help avoid language that may later be seen to be confusing or ambiguous.

Further Information

The TQ Delta decision can be found here.

Tags

license agreement

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Global IP Enforcement, Litigation, and Trials

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Related Offices

Washington, DC

Related Professionals

John C. Paul
Partner
Washington, DC
+1 202 408 4109
Email
D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email
Sonja W. Sahlsten
Partner
Washington, DC
+1 202 408 4329
Email

Copyright © Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP